TGA reforms

5 February 2015

The TGA mandate is to regulate medicines, medical devices and biological products throughout their lifecycle. The TGA is focusing on implementing changes to ensure a greater emphasis on transparency of regulatory decision-making processes, a continuing focus on business process reform and a more strategic approach to the use of information technology to support regulatory operations.

Reforms underway as part of TGA Reforms: a blueprint for TGA's future include: